Raltegravir (Isentress)

Published November 13, 2007; Updated March 2018
Susa Coffey, MD
Selected Reference
13. Hazuda DJ, Miller MD, Nguyen BY, et al, Resistance to the HIV-integrase inhibitor raltegravir: analysis of protocol 005, a phase II study in patients with triple-class resistant HIV-1 infection. In: Program and abstracts of the XVI International HIV Drug Resistance Workshop; June 12-16, 2007; St. Michael, Barbados. Abstract 8.